Skip to main content
. 2017 Dec 27;9(7):7372–7388. doi: 10.18632/oncotarget.23677

Figure 2. Paeoniflorin suppresses RANKL-induced osteoclast F-actin ring formation and bone resorption activity.

Figure 2

(A) Representative confocal images of osteoclasts stained for F-actin, TRAP stained bone slice, and SEM scanned bone slice in untreated osteoclasts, and osteoclasts treated with 1 μM and 10 μM of paeoniflorin. (B) Quantitative analysis of osteoclasts with complete actin. (C) Quantitative analysis of bone resorbed area. (D) Quantitative analysis of average pit depth. Data are presented as mean ± SD; *P < 0.05.